Latanoprost/timolol fixed combination for the treatment of glaucoma

Konstas A. G. P., MOCAN M. C., Katsanos A., Voudouragkaki I. C., Irkec M.

EXPERT OPINION ON PHARMACOTHERAPY, cilt.14, sa.13, ss.1815-1827, 2013 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 14 Sayı: 13
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1517/14656566.2013.813482
  • Dergi Adı: EXPERT OPINION ON PHARMACOTHERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1815-1827
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Introduction: Glaucoma is a multifactorial optic neuropathy that can lead to progressive and irreversible loss of vision. Today there are > 60 million glaucoma patients worldwide, and this figure is rising due to aging. The aim of glaucoma therapy is to maintain the patient's visual function and quality of life by means of intraocular pressure (IOP) reduction, which currently constitutes the only evidence-based approach.